From surviving to thriving: a framework for long-term success in people with HIV

NewsMedical spoke to Lisa Sterman, Global Executive Director, Global HIV Medical Affairs, Gilead Sciences, about the recently published LTS framework, recently highlighted at the opening ceremony of the 19th European AIDS Conference, which takes a person-centric approach to the HIV treatment journey.

Basecamp raises $60M to travel the globe and fill AI data gaps, signs deal with David Liu

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 10, 2024

FDA grants fast track status to FELIQS’s FLQ-101 for ROP

ROP affected 27,000 premature neonates in the US in 2019. Credit: ANNA GRANT/Shutterstock. The US Food and Drug Administration (FDA) has granted fast track designation

November 4, 2024

J&J touts success of nipocalimab in two rare disease trials

Share this article J&J has reported positive data for nipocalimab in multiple autoantibody-driven diseases, such as generalised myasthenia gravis (gMG), Sjogren’s disease, haemolytic disease of

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.